PATENT CLAIM ANALYSIS

Application Number: 16172100
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "649000"]

Abstract:
A hitherto unknown crystalline form of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride, pharmaceutical compositions containing the new crystalline form, methods of producing the new crystalline form, and a related method of use including treatment of, e.g., pain and/or urinary incontinence.

Claim (Index 8):
The process of  claim 7 , wherein said solvent is the same as that used to form the (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride of crystalline Form A before the step of redissolving.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12634777', '12329111', '12016506', '12850208', '15033331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7400184671470202
- 35 USC 102 Novelty (BERT): 0.5691230933471921
- Combined Prediction Score: 0.7229289297670375
- Mean Citation Score: 271.66068
- Max Citation Score: 446.01437
- Similarity Product: 350.16279059553864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test